Differential sensitivities among immune cell subsets (e.g., Tregs express higher GPX4/SLC7A11 and are relatively ferroptosis-resistant) raise the possibility that ferroptosis induction could selectively deplete tumor cells while sparing or relatively enriching suppressive immune subsets, thereby blunting antitumor immunity [101]. The gene discussed is SLC7A11; the disease is neoplasm.